MKI67 and neoplasm: To investigate whether background of the BALB/c substrain affects the cell proliferation ability of CT26 tumor after cisplatin treatment, immunofluorescence (IF) intensity for the Ki67 protein was measured on CT26 tumor sections obtained from the three syngeneic BALB/c substrains after exposure to cisplatin for 14 days.